Please select a location from the dropdown to view relevant share classes and investments. Your home market is currently
Don't see your home market? Change Edition

Airbus Earnings: Sprinting to Meet 2025 Goal of 820 Jets Delivered; Shares Fully Valued

We think Airbus Group stock is moderately overvalued.

Closeup of the logo of Airbus displayed on the pavilion of Airbus aerospace corporation.
Nicolas Economou via Getty

Key Morningstar Metrics for Airbus Group

What We Thought of Airbus Group’s Earnings

Airbus reported EUR 17.8 billion in third-quarter sales, up 14% from 2024, with midteens increases across its commercial jet, defense, and helicopter businesses. The company delivered 507 jets through September, leaving just about one-third to be built in the final quarter.

Why it matters: Commercial planes are 70% of its sales, so Airbus’ progress in increasing commercial jet output in the face of robust demand leads its fortunes. However, it is constrained primarily by the delayed supply of jet engines from suppliers CFM and Pratt & Whitney.

  • Airbus completed the second quarter with 32 so-called “gliders” on hand, down from 60 at the end of June; gliders are jets completed and ready for customer delivery but for their lack of engines. Management indicated that its engine supply chain shows signs of recovery, which is promising considering how many jets it still plans to build in 2025.
  • The company has sprinted to the year-end finish before: in 2023 management promised 720 jets and delivered 735, and in 2024 the company initially promised 800, reduced it to 770 because of engine bottlenecks, and delivered 766. In both years, fourth-quarter jet deliveries represented more than one third of the annual total.

The bottom line: With slight improvement and line of sight to its multidecade growth trajectory, we have increased our fair value estimate for this wide-moat manufacturer to EUR 189 from EUR 184 per share and to $55 from $53 per US depository receipt.

Editor's Note: This analysis was originally published as a stock note by Morningstar Equity Research.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.